EX-99.1 3 atec-ex99_1.htm EX-99.1 EX-99.1

 

img43239604_0.jpg

第99.1展示文本

 

ATEC发布2024年第三季度财务结果

并提高了全年指引

 

手术收入增长30%; 总收入增长27%

全年营业收入和盈利指导增加

通过对现有贷款设施进行5,000万美元扩容,提高资产负债表灵活性

2024年10月30日,加利福尼亚州卡尔斯巴德 - Alphatec Holdings, Inc.(纳斯达克:ATEC)是一家致力于革新脊柱手术方法的创新解决方案提供商,今天宣布了截至2024年9月30日的季度财务业绩和最新企业亮点。

2024年第三季度 金融 结果

季度结束

2024年9月30日

总收入

$15100万

GAAP毛利率

68%

非GAAP毛利率

69%

GAAP营业费用

$13600万

非GAAP营业费用

11400万美元

GAAP净损失

(40)百万美元

调整后的EBITDA

740万美元

调整后的EBITDA率

5%

期末现金余额

8100万美元

最近的亮点

在持续增长的机会挚诚和量子钮方面推动了20%的程序性成交量增长此款超便携式投影仪使用了最新的 Android TV 界面,而且遥控器还内置了 Google AssistantTM 功能,用户可以非常方便地使用它。 和长期股东此款超便携式投影仪使用了最新的 Android TV 界面,而且遥控器还内置了 Google AssistantTM 功能,用户可以非常方便地使用它。;
新外科医生采用率增长19%,这是未来增长的重要领先指标;
继续扩大美国市场份额,促成200多次外科医生培训项目;
随着加速投资阶段接近尾声,自由现金使用额减少至2100万美元。

“在ATEC,我们的承诺继续致力于通过创新提升脊柱护理,”Pat Miles,董事长兼首席执行官说。“这一承诺在过去五年中推动了我们的增长,增长率是我们行业的数倍。我们意识到将增长转化为扩大利润的重要性,以便支持我们的长期愿景,我们正在积极执行内部举措来影响现金流。我们对未来机遇的看法保持不变:我们正在打造一家特别的公司,其独特地位使其能够彻底改革脊柱护理。”

 

提高现有的长期债务融资额


 

img43239604_1.jpg

 

 

公司已与Braidwell LP和Pharmakon Advisors, LP达成协议,将公司现有的贷款额度扩大5000万美元,可获得高达20000万美元的总容量。随着交易的完成,公司拥有约12800万美元的预计现金。

Pharmakon Advisors的联合创始人、首席执行官Pedro Gonzalez de Cosio表示:“ATEC旨在改善脊柱护理,正在推动非凡增长。我们很高兴能与团队合作,支持这一重要使命,随着公司继续扩大盈利能力并转向正现金流方面。”

关于融资的更多细节将包含在一份8-k表格的当前报告中,ATEC将在今天向证券交易委员会提交。

财务展望 2024年度整年

截止2024年12月31日结束的财政年度,公司现预计总营业收入将增长25%,达到60500万美元,较先前预期的60200万美元。其中包括手术收入54000万美元和柚子收入6500万美元。公司现预计非GAAP调整后的EBITDA约为2700万美元,较先前预期的2550万美元。

财务业绩网络研讨会

ATEC将于今天下午1:30时(太平洋时间)/下午4:30时(东部时间)通过现场网络研讨会公布这些结果。访问ATEC公司网站的投资者关系部分即可进入现场网络研讨会。

 

想要参加直播网络研讨会,请在此链接注册。访问详情将通过电子邮件分享。

网络直播的重播将在ATEC公司网站的投资者关系部门保留12个月。

非依据GAAP制定的财务信息

为了补充按照美国通用会计准则(GAAP)编制的公司财务报表,公司报告了某些非GAAP财务指标,包括非GAAP毛利率、非GAAP营业费用、非GAAP营业亏损和非GAAP调整后的EBITDA。公司认为这些非GAAP财务指标为投资者提供了一个评估公司核心业绩的额外工具,管理层在评估持续经营业绩时使用,以及评估公司未来盈利潜力的基准。公司的非GAAP财务指标可能无法提供直接可比的信息,因为公司行业板块的其他公司可能以不同方式计算非GAAP财务结果,特别是与非常规、飞凡项目有关的情况。非GAAP财务结果应被视为补充,而非替代或优于按照GAAP计算的财务指标。下面包括非GAAP财务指标与可比GAAP财务指标的调解。

 

关于 Alphatec Holdings,Inc.公司


 

img43239604_1.jpg

 

 

阿尔法泰克通过其全资子公司Alphatec Spine, Inc.,柚子成像S.A.S.和SafeOp Surgical, Inc.,是一家专注于通过临床卓越革新脊柱外科手术方法的器械公司。ATEC的有机创新机器致力于开发与公司不断扩大的AlphaInformatiX平台无缝集成的新方法,以更好地为手术提供信息,并更安全、更可靠地达到脊柱外科手术的目标。ATEC的愿景是成为脊柱领域的标杆。欲了解更多信息,请访问我们的网站www.atecspine.com。

 


 

img43239604_1.jpg

 

 

前瞻性声明

本新闻发布包含根据1995年《私人证券诉讼改革法案》的“前瞻性陈述”,涉及风险和不确定性。此类陈述基于管理层的当前期望,并受到一系列可能导致实际结果与前瞻性陈述描述不符的风险和不确定性。公司提醒投资者,无法保证实际结果不会因各种因素而与这类前瞻性陈述中所述的投射或建议有实质性不同。前瞻性陈述包括但不限于: 关于公司的营业收入、资产负债表、增长和财务前景与承诺的引用; 公司促使外科医生采用、推动程序增长和转变销售渠道的能力。可能导致实际运营结果与此类前瞻性陈述所表达或暗示的结果显著不同的重要因素包括但不限于: 在开发新产品或当前正在研发阶段的产品方面获得成功的不确定性; 公司执行战略运营计划的不确定性; 成功许可或收购新产品以及这些产品的商业成功的不确定性; 未能取得外科医生社区对公司产品的认可; 未能获得FDA或其他监管机构的批准或意外或进展时间过长的延迟的风险; 有利的第三方赔偿持续性; 突发费用或负债或影响现金流或公司实现盈利能力的其他不利事件的不确定性; 额外资金及其形式的不确定性; 产品责任风险; 任何诉讼的不成功结果; 侵犯专利的索赔; 与公司知识产权相关的索赔; 以及公司履行其财务义务的能力。这些和其他因素、风险和不确定性的进一步清单和描述可在公司最近的年度报告以及向证券交易委员会提交的任何后续季度和当前报告中找到。ATEC否认有意或义务更新或修改任何前瞻性陈述,除非法律要求。

Non-GAAP Definitions

Amortization of intangible assets: Represents amortization expense associated with intangible assets including, but not limited to customer relationships, intellectual property, and trade names acquired in business combinations and asset acquisitions.

Litigation-related expenses: We are involved in various litigation matters that from time-to-time result in settlements. Litigation matters can vary in their characteristics, frequency and significance to our operating results and core business operations. We review litigation matters from both a qualitative and quantitative perspective to determine whether such matters are a normal and recurring part of our business. We include in our GAAP financial statements litigation fees and settlement expenses that we determine to be normal, recurring and routine to our business. When we determine that certain litigation matters are not normal and recurring to our core business operations, we believe excluding these expenses will provide our management and investors with useful incremental information. Litigation fees and settlement expenses excluded from our non-GAAP financial measures in the periods presented relate primarily to patent litigation and other litigation matters that relate directly to the business transformation that we started in 2018 and are discussed more fully in our periodic reports filed with the Securities Exchange Commission.

Other non-recurring expenses: These expenses represent non-recurring expenses that we consider to be one-time in nature.


 

img43239604_1.jpg

 

 

Purchase accounting adjustments on acquisitions: Includes non-cash expenses incurred as a result of fair value asset step-ups associated with tangible assets acquired from business combinations or asset acquisitions.

Restructuring expenses: From time-to-time, in order to realign the Company’s operations or to achieve synergies associated with an acquisition, the Company may eliminate roles or restructure its operations and footprint. In such cases the Company may incur one-time severance and personnel costs associated with workforce reductions, or costs associated with exiting and/or relocating facilities. We exclude these costs as we do not consider such amounts to be part of the ongoing operations.

Stock-based compensation: Stock-based compensation is charged to cost of revenue and operating expenses. We exclude stock-based compensation from certain of our non-GAAP financial measures because we believe that excluding these non-cash expenses provides meaningful supplemental information regarding operational performance. Because of the variety of equity awards used by companies, the varying methodologies for determining stock-based compensation expense, the subjective assumptions involved in those determinations, and the volatility in valuations that can be driven by market conditions outside the Company’s control, the Company believes excluding stock-based compensation expense enhances the ability of management and investors to understand and assess the underlying performance of its business over time.

Transaction-related expenses: These expenses represent one-time costs associated with business combinations and asset acquisitions. These items may include but are not limited to consulting and legal fees, contract termination costs and other related deal costs.

Adjusted EBITDA: Represents earnings before non-operating income/expense, taxes, depreciation and amortization, as adjusted for the applicable non-GAAP adjustments previously described.

Investor/Media Contact:

Tina Jacobsen, CFA

Investor Relations

(760) 494-6790

investorrelations@atecspine.com

Company Contact:

J. Todd Koning

Chief Financial Officer

investorrelations@atecspine.com

 


 

img43239604_1.jpg

 

 

ALPHATEC HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

 

(unaudited)

 

 

(unaudited)

 

Revenue from products and services

 

$

150,719

 

 

$

118,262

 

 

$

434,769

 

 

$

344,292

 

Cost of sales

 

 

47,990

 

 

 

38,215

 

 

 

132,095

 

 

 

129,279

 

Gross profit

 

 

102,729

 

 

 

80,047

 

 

 

302,674

 

 

 

215,013

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

20,357

 

 

 

20,000

 

 

 

57,474

 

 

 

47,831

 

Sales, general and administrative

 

 

109,200

 

 

 

91,411

 

 

 

335,658

 

 

 

269,960

 

Litigation-related expenses

 

 

2,093

 

 

 

2,715

 

 

 

8,611

 

 

 

12,815

 

Amortization of acquired intangible assets

 

 

3,848

 

 

 

3,873

 

 

 

11,538

 

 

 

10,461

 

Transaction-related expenses

 

 

 

 

 

278

 

 

 

(117

)

 

 

2,178

 

Restructuring expenses

 

 

934

 

 

 

129

 

 

 

1,861

 

 

 

333

 

Total operating expenses

 

 

136,432

 

 

 

118,406

 

 

 

415,025

 

 

 

343,578

 

Operating loss

 

 

(33,703

)

 

 

(38,359

)

 

 

(112,351

)

 

 

(128,565

)

Other expense, net:

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

 

(6,572

)

 

 

(4,459

)

 

 

(17,728

)

 

 

(12,225

)

Other income, net

 

 

623

 

 

 

47

 

 

 

897

 

 

 

3,077

 

Total other expense, net

 

 

(5,949

)

 

 

(4,412

)

 

 

(16,831

)

 

 

(9,148

)

Net loss before taxes

 

 

(39,652

)

 

 

(42,771

)

 

 

(129,182

)

 

 

(137,713

)

Income tax benefit

 

 

(36

)

 

 

(117

)

 

 

(391

)

 

 

(153

)

Net loss

 

$

(39,616

)

 

$

(42,654

)

 

$

(128,791

)

 

$

(137,560

)

Net loss per share, basic and diluted

 

$

(0.28

)

 

$

(0.35

)

 

$

(0.90

)

 

$

(1.18

)

Weighted average shares outstanding, basic and diluted

 

 

143,492

 

 

 

122,468

 

 

 

142,400

 

 

 

117,026

 

Stock-based compensation included in:

 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

$

1,439

 

 

$

2,369

 

 

$

2,476

 

 

$

24,601

 

Research and development

 

 

7,207

 

 

 

6,790

 

 

 

17,137

 

 

 

9,587

 

Sales, general and administrative

 

 

8,816

 

 

 

10,914

 

 

 

32,131

 

 

 

26,541

 

 

 

$

17,462

 

 

$

20,073

 

 

$

51,744

 

 

$

60,729

 

 


 

img43239604_1.jpg

 

 

ALPHATEC HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

 

 

 

September 30,
2024

 

 

December 31,
2023

 

 

 

(unaudited)

 

 

 

 

ASSETS

 

Current assets:

 

 

 

 

 

 

 Cash and cash equivalents

 

$

80,976

 

 

$

220,970

 

 Accounts receivable, net

 

 

78,452

 

 

 

72,613

 

 Inventories

 

 

183,111

 

 

 

136,842

 

 Prepaid expenses and other current assets

 

 

19,886

 

 

 

20,666

 

Total current assets

 

 

362,425

 

 

 

451,091

 

Property and equipment, net

 

 

171,430

 

 

 

149,835

 

Right-of-use assets

 

 

37,015

 

 

 

26,410

 

Goodwill

 

 

73,397

 

 

 

73,003

 

Intangible assets, net

 

 

98,785

 

 

 

102,451

 

Other assets

 

 

2,843

 

 

 

2,418

 

Total assets

 

$

745,895

 

 

$

805,208

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

Current liabilities:

 

 

 

 

 

 

 Accounts payable

 

$

59,578

 

 

$

48,985

 

 Accrued expenses and other current liabilities

 

 

76,262

 

 

 

87,712

 

 Contract liabilities

 

 

11,602

 

 

 

13,910

 

 Short-term debt

 

 

1,790

 

 

 

1,808

 

 Current portion of operating lease liabilities

 

 

6,989

 

 

 

5,159

 

Total current liabilities

 

 

156,221

 

 

 

157,574

 

 Total long-term liabilities

 

 

567,433

 

 

 

545,915

 

 Redeemable preferred stock

 

 

23,603

 

 

 

23,603

 

 Stockholders' equity

 

 

(1,362

)

 

 

78,116

 

Total liabilities and stockholders' equity

 

$

745,895

 

 

$

805,208

 

 


 

img43239604_1.jpg

 

 

ALPHATEC HOLDINGS, INC.

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

(in thousands)

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

 

September 30,

 

 

September 30,

 

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

(unaudited)

 

 

 

 

 

 

 

Gross profit, GAAP

 

$

102,729

 

 

$

80,047

 

 

$

302,674

 

 

$

215,013

 

 

Add: amortization of intangible assets

 

 

308

 

 

 

221

 

 

 

922

 

 

 

661

 

 

Add: stock-based compensation

 

 

1,439

 

 

 

2,369

 

 

 

2,476

 

 

 

24,601

 

 

Add: purchase accounting adjustments on acquisitions

 

 

 

 

 

 

 

 

197

 

 

 

195

 

 

Non-GAAP gross profit

 

$

104,476

 

 

$

82,637

 

 

$

306,269

 

 

$

240,470

 

 

Gross margin, GAAP

 

 

68.2

%

 

 

67.7

%

 

 

69.6

%

 

 

62.5

%

 

Add: amortization of intangible assets

 

 

0.2

%

 

 

0.2

%

 

 

0.2

%

 

 

0.2

%

 

Add: stock-based compensation

 

 

1.0

%

 

 

2.0

%

 

 

0.6

%

 

 

7.1

%

 

Add: purchase accounting adjustments on acquisitions

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

 

0.1

%

 

Non-GAAP gross margin

 

 

69.3

%

 

 

69.9

%

 

 

70.4

%

 

 

69.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

 

September 30,

 

 

September 30,

 

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

(unaudited)

 

 

 

 

 

 

 

Operating expenses, GAAP

 

$

136,432

 

 

$

118,406

 

 

$

415,025

 

 

$

343,578

 

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

(16,023

)

 

 

(17,704

)

 

 

(49,268

)

 

 

(36,128

)

 

Litigation-related expenses

 

 

(2,093

)

 

 

(2,715

)

 

 

(8,611

)

 

 

(12,815

)

 

Amortization of intangible assets

 

 

(3,848

)

 

 

(3,873

)

 

 

(11,538

)

 

 

(10,461

)

 

Transaction-related expenses

 

 

 

 

 

(278

)

 

 

117

 

 

 

(2,178

)

 

Restructuring expenses

 

 

(934

)

 

 

(129

)

 

 

(1,861

)

 

 

(333

)

 

Other non-recurring expenses1, 2

 

 

 

 

 

 

 

 

(1,608

)

 

 

(1,349

)

 

Non-GAAP operating expenses

 

$

113,534

 

 

$

93,707

 

 

$

342,256

 

 

$

280,314

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

 

September 30,

 

 

September 30,

 

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

(unaudited)

 

 

 

 

 

 

 

Net loss, GAAP

 

$

(39,616

)

 

$

(42,654

)

 

$

(128,791

)

 

$

(137,560

)

 

Other expense, net

 

 

5,949

 

 

 

4,412

 

 

 

16,831

 

 

 

9,148

 

 

Income tax benefit

 

 

(36

)

 

 

(117

)

 

 

(391

)

 

 

(153

)

 

Depreciation

 

 

16,491

 

 

 

10,651

 

 

 

45,950

 

 

 

28,998

 

 

Amortization of intangible assets

 

 

4,156

 

 

 

4,094

 

 

 

12,460

 

 

 

11,122

 

 

EBITDA

 

 

(13,056

)

 

 

(23,614

)

 

 

(53,941

)

 

 

(88,445

)

 

Add back significant items:

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

17,462

 

 

 

20,073

 

 

 

51,744

 

 

 

60,729

 

 

Purchase accounting adjustments on acquisitions

 

 

 

 

 

 

 

 

197

 

 

 

195

 

 

Litigation-related expenses

 

 

2,093

 

 

 

2,715

 

 

 

8,611

 

 

 

12,815

 

 

Transaction-related expenses

 

 

 

 

 

278

 

 

 

(117

)

 

 

2,178

 

 

Restructuring expenses

 

 

934

 

 

 

129

 

 

 

1,861

 

 

 

333

 

 

Other non-recurring expenses1, 2

 

 

 

 

 

 

 

 

1,608

 

 

 

1,349

 

 

Adjusted EBITDA

 

$

7,433

 

 

$

(419

)

 

$

9,963

 

 

$

(10,846

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA margin

 

 

4.9

%

 

 

(0.4

%)

 

 

2.3

%

 

 

(3.2

%)

 

Adjusted EBITDA margin expansion

 

530 bps

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

Non-recurring net charges on assets and liabilities associated with customer plan of reorganization

 

2

Non-recurring consulting fees associated with the implementation of our state tax-planning strategy